Cite
HARVARD Citation
Falloon, J. et al. (2016). A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant. Vaccine. 34 (25), pp. 2847-2854. [Online].